JDRF Statement on NHS England’s COVID-19 Study
“A study published by NHS England provides greater insight into understanding how people with type 1 diabetes (T1D) may be affected by COVID-19. The study, which examines patients within the U.K. hospital system, showed an increased risk of fatality in individuals with T1D hospitalized with the coronavirus compared to type 2 diabetes and the general population.
Independently, the risk of fatality due to COVID-19—for people with and without diabetes remains very low. Research has indicated that other factors, including age and poor health, continue to be the leading determinants in increased risk.
People with T1D can help reduce their risk by following previously outlined CDC guidelines, which include frequent handwashing, social distancing, disinfecting surfaces, and covering of the face and nose when around others. As always, it’s important to manage T1D as well as possible by closely monitoring blood sugar levels.
In these challenging times, JDRF is continuing to do all it can to help the T1D community stay informed on the virus. We encourage everyone to visit JDRF.org/Coronavirus or coronavirusdiabetes.org for more information about COVID-19 and T1D.”
JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF